Tinnitus Treatment With Piribedil Guided by Acoustic Otoemissions and Electrocochleography
NCT ID: NCT00591994
Last Updated: 2008-03-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2006-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cochlear Promontory Stimulation for Treatment of Tinnitus
NCT03759834
Clinical Trial of Sound-Based Versus Behavioral Therapy for Tinnitus
NCT03022084
Efficacy Study for Development and Use of Neurofeedback-trainings for Patients Suffering From Chronic Tinnitus
NCT02383147
ICCAC-ToNF & Tinnitus
NCT03895047
Resting-State Neural Connectivity in Patients With Subjective Tinnitus Without Bother
NCT01049828
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
TRIPLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
piribedil
50 mg once a day, after lunch 3 month therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* THI \> 38
* no central acting drugs in the last 6 months
* tympanogram type A-n
Exclusion Criteria
* concomitant TMJ disorders
* abnormal otoscopy
* mixed and conductive hearing losses
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Faculdade de Medicina de Valenca
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
OTOSUL
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ricardo R Figueiredo, M.D.,M.Sc
Role: STUDY_CHAIR
Faculdade de Medicina de Valença
Andréia A Azevedo, M.D.
Role: PRINCIPAL_INVESTIGATOR
Otosul -Otorrinolaringologia Sul-Fluminense
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
OTOSUL,Otorrinolaringologia Sul-Fluminense
Volta Redonda, Rio de Janeiro, Brazil
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
de Azevedo AA, Langguth B, de Oliveira PM, Rodrigues Figueiredo R. Tinnitus treatment with piribedil guided by electrocochleography and acoustic otoemissions. Otol Neurotol. 2009 Aug;30(5):676-80. doi: 10.1097/MAO.0b013e3181ab8fd5.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FMV 01/2006
Identifier Type: -
Identifier Source: secondary_id
OTOSUL 01/2007
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.